Previous 10 | Next 10 |
home / stock / dva / dva articles
JAMES HEARTY, Chief Compliance Officer at DaVita (NYSE:DVA), reported an insider sell on February 21, according to a new SEC filing. What Happened...
Tuesday, Fresenius Medical Care AG (NYSE:FMS) reported fourth-quarter 2023 revenue of €4.9 billion ($5.37 billion, almost in line with ...
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. Shares of Charles River Laboratories International, I...
The markets exhibited a mixed trend Monday, with technology heavyweights experienced a slight downturn as investors adopt a cautious approach ahead...
Novo Nordisk A/S (NYSE: NVO) shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney f...
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TP...
Risk sentiment weakened during Wednesday trading on Wall Street, following significant gains in the previous session. This shift was triggered by h...
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fell sharpl...
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares rose 279.8% to $0.9115 in pre-market trading, after the company announced it plans to rep...
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, today announced the extension of its pilot phase under its previously announced supply and collaborati...